CD4 and neoplasm: Thus, we performed a multiplex immunohistological (mIHC) analysis to investigate major lymphocytic and myeloid immune cell populations by staining with antibodies for CD4, CD8, Ly6G, CD11b, and F4/80 together with the tumor-epithelial cell marker panCytokeratin (Fig. 4G).